The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S,4R)-1-((S)-2-(3-(2-(5-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)pentyloxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide ID: ALA4587573
Cas Number: 2230821-27-7
PubChem CID: 135156947
Product Number: G287801, Order Now?
Max Phase: Preclinical
Molecular Formula: C47H57ClFN7O8S
Molecular Weight: 934.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCOCCOCCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C
Standard InChI: InChI=1S/C47H57ClFN7O8S/c1-29-42(65-28-53-29)31-11-9-30(10-12-31)25-50-45(59)38-22-33(57)26-56(38)46(60)43(47(2,3)4)55-41(58)15-18-63-20-19-62-16-7-6-8-17-64-40-23-34-37(24-39(40)61-5)51-27-52-44(34)54-32-13-14-36(49)35(48)21-32/h9-14,21,23-24,27-28,33,38,43,57H,6-8,15-20,22,25-26H2,1-5H3,(H,50,59)(H,55,58)(H,51,52,54)/t33-,38+,43-/m1/s1
Standard InChI Key: NICKHWYZMNLEPJ-TZSMONEZSA-N
Molfile:
RDKit 2D
65 70 0 0 0 0 0 0 0 0999 V2000
-7.7949 -4.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7938 -5.1613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.0903 -5.5703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0885 -3.9329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.3774 -4.3382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.3781 -5.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6669 -5.5643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9636 -5.1535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9672 -4.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6778 -3.9280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.0839 -6.3875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.7887 -6.7977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2609 -3.9184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2641 -3.1013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2532 -5.5593 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.5478 -5.1480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8373 -5.5538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1319 -5.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4214 -5.5483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7160 -5.1370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0056 -5.5428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.5007 -6.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2060 -6.7970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.2074 -7.6150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.4930 -8.0218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7849 -7.6099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.9173 -6.3897 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-9.9127 -8.0262 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.7034 -5.1315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4127 -5.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1188 -5.1260 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8281 -5.5318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5342 -5.1205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2435 -5.5263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9496 -5.1150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2467 -6.3435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6589 -5.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3650 -5.1094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6621 -6.3380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9560 -6.7493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3714 -6.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6543 -7.1525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0743 -5.5153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3619 -4.2923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1598 -6.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9598 -6.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3657 -5.7851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8164 -5.1801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2951 -7.2397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9825 -4.3799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7585 -4.1237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3684 -4.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1444 -4.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3727 -3.8360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7508 -4.9555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5261 -4.6999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6929 -3.8990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0781 -3.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3051 -3.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4685 -3.6418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1307 -4.1203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7889 -3.6359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5317 -2.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7145 -2.8653 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.1342 -4.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
11 12 1 0
9 13 1 0
13 14 1 0
8 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
12 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 12 1 0
23 27 1 0
24 28 1 0
21 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
34 36 2 0
37 35 1 0
37 38 1 0
37 39 1 6
39 40 1 0
39 41 1 0
39 42 1 0
38 43 1 0
38 44 2 0
43 45 1 0
45 46 1 0
46 47 1 0
47 48 1 0
48 43 1 0
46 49 1 1
48 50 1 6
50 51 1 0
51 52 1 0
52 53 1 0
50 54 2 0
53 55 2 0
55 56 1 0
56 57 2 0
57 58 1 0
58 59 2 0
59 53 1 0
57 60 1 0
60 61 2 0
61 62 1 0
62 63 2 0
63 64 1 0
64 60 1 0
61 65 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 934.53Molecular Weight (Monoisotopic): 933.3662AlogP: 7.39#Rotatable Bonds: 22Polar Surface Area: 186.36Molecular Species: NEUTRALHBA: 13HBD: 4#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 4#RO5 Violations (Lipinski): 3CX Acidic pKa: 12.50CX Basic pKa: 5.04CX LogP: 5.43CX LogD: 5.43Aromatic Rings: 5Heavy Atoms: 65QED Weighted: 0.05Np Likeness Score: -0.90
References 1. Cheng M, Yu X, Lu K, Xie L, Wang L, Meng F, Han X, Chen X, Liu J, Xiong Y, Jin J.. (2020) Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders., 63 (3): [PMID:31895569 ] [10.1021/acs.jmedchem.9b01566 ] 2. Zhao HY,Yang XY,Lei H,Xi XX,Lu SM,Zhang JJ,Xin M,Zhang SQ. (2020) Discovery of potent small molecule PROTACs targeting mutant EGFR., 208 [PMID:32883633 ] [10.1016/j.ejmech.2020.112781 ] 3. García Jiménez D, Rossi Sebastiano M, Vallaro M, Mileo V, Pizzirani D, Moretti E, Ermondi G, Caron G.. (2022) Designing Soluble PROTACs: Strategies and Preliminary Guidelines., 65 (19.0): [PMID:35469399 ] [10.1021/acs.jmedchem.2c00201 ] 4. Yu X, Cheng M, Lu K, Shen Y, Zhong Y, Liu J, Xiong Y, Jin J.. (2022) Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras., 65 (12.0): [PMID:35675209 ] [10.1021/acs.jmedchem.2c00345 ] 5. Wang C, Zhang Y, Wang J, Xing D.. (2022) VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives., 227 [PMID:34656901 ] [10.1016/j.ejmech.2021.113906 ] 6. Zhao HY, Wang HP, Mao YZ, Zhang H, Xin M, Xi XX, Lei H, Mao S, Li DH, Zhang SQ.. (2022) Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands., 65 (6.0): [PMID:35254067 ] [10.1021/acs.jmedchem.1c01827 ]